A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers

Overview of attention for article published in PLOS ONE, January 2013

Altmetric Badge

Mentioned by

twitter: 1 X user
patent: 3 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 46 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

METHOD FOR SELECTING A THERAPY FOR THE TREATMENT OF COLORECTAL CANCER PATIENTS

Application EP-3373010-A1

European Patent Office

Methods for predicting and improving the survival of colorectal cancer patients

Grant US-9903867-B2

United States of America

METHODS FOR PREDICTING AND IMPROVING THE SURVIVAL OF COLORECTAL CANCER PATIENTS

Application WO-2014188363-A1

World Intellectual Property Organisation (WIPO)